Skip to Content

Join the 'Sensipar' group to help and get support from people like you.

Sensipar News

FDA Medwatch Alert: Sensipar (Cinacalcet Hydrochloride): Drug Safety Communication - FDA Suspends Pediatric Clinical Trials After Report Of Death

Posted 26 Feb 2013 by

ISSUE: FDA has stopped all pediatric clinical trials of Sensipar (cinacalcet hydrochloride) after the recent death of a 14-year-old patient in a trial.  Posting this information does not mean that FDA has concluded whether or not Sensipar had a role in the patient’s death. This communication is intended to inform health care professionals that we are evaluating the information and will co ...

Ask a Question

Further Information

Related Condition Support Groups

Primary Hyperparathyroidism, Secondary Hyperparathyroidism, Hypercalcemia of Malignancy

Sensipar Patient Information at